Skip to search formSkip to main contentSkip to account menu

LY2605541

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Insulin LisproPolyethylene Glycols

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
LY2605541 (LY) exhibits a Flatter Glucodynamic profile than insulin Glargine (GL) at steady state in subjects with Type 1 Diabetes (T1D)
2013
2013
Contrasting weight changes with LY2605541, a novel long-acting insulin, and insulin glargine despite similar improved glycemic control in T1D and T2D
2013
2013
The novel long-acting insulin LY2605541 is superior to insulin glargine in lowering intra-day glucose variability and hypoglycemia event rate from Continuous Glucose Monitoring (CGM) in patients with…